Form 4: MeiraGTx Holdings CFO Richard Giroux Reports Share Transactions Following Vesting of Restricted Share Units
SEC Form 4 Filing
Richard Giroux, CFO & COO of MeiraGTx Holdings, reported the vesting of restricted share units and subsequent share transactions on January 7, 2025.
Summary
- Richard Giroux, the CFO & COO of MeiraGTx Holdings, reported transactions related to the vesting of restricted share units.
- On January 7, 2025, 52,500 restricted share units vested, converting into 52,500 ordinary shares.
- A total of 27,760 shares were withheld to cover tax obligations at a price of $6.34 per share.
- Following these transactions, Mr. Giroux directly owns 862,166 ordinary shares.
- He also indirectly owns 5,152 shares through his spouse and 85,000 shares through Aigle Healthcare Partners III LLC.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation. It is neither particularly positive nor negative, but rather a standard process. The sentiment is neutral to slightly positive as it indicates the executive is receiving compensation.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the standard practice of granting restricted share units to executives as part of their compensation packages.
Comparison to Industry Standards
- The vesting of restricted share units is a common practice in the biotechnology industry, used to align executive interests with shareholder value.
- Many companies, such as BioMarin Pharmaceutical and Vertex Pharmaceuticals, use similar equity compensation plans for their executives.
- The tax withholding process is also standard, where a portion of shares are sold to cover the tax liability associated with the vesting of equity awards.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect the standard vesting of executive compensation.
- The sale of shares to cover taxes may have a slight downward pressure on the share price, but this is typically minimal.
Key Dates
| Date | Description |
|---|---|
| 01/07/2022 | Date of grant for the restricted share units that vested on January 7, 2025. |
| 01/07/2025 | Date of vesting of restricted share units and subsequent share transactions. |
| 01/10/2025 | Date of signature for the Form 4 filing. |
Keywords
MeiraGTx Holdings, Richard Giroux, restricted share units, share vesting, insider trading, Form 4, MGTX, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.